Answers are grounded in this paper and cite their sources.
RATIONALE: Globally, 604.8 million women and 269 million children are living with anaemia; reducing anaemia is a key goal of the 2030 Global Strategy for Women's, Children's, and Adolescents' Health. OBJECTIVES: To determine the benefits and harms of daily oral iron supplementation in infants, children and adolescents 0-19 years of age with or without anaemia caused by iron deficiency (IDA). SEARCH METHODS: We searched CENTRAL, MEDLINE, CINAHL, 16 additional databases, and two trial registries up to January 2025. ELIGIBILITY CRITERIA: We included 0-19-year-olds regardless of baseline iron or anaemia status. We included randomised controlled trials (RCTs) and quasi-RCTs assessing the effects of daily oral supplementation of iron alone, iron with folic acid (IFA), or iron with other vitamins or minerals or both (iron + vitamins/minerals) versus no intervention/placebo. OUTCOMES: Critical outcomes were anaemia, ID, IDA, growth, morbidity (respiratory illness, cough/difficulty breathing, diarrhoea, fever), and adverse events (AE) (vomiting, diarrhoea, constipation, and stool discolouration). RISK OF BIAS: We used the Risk of bias (RoB) 1 tool. SYNTHESIS METHODS: We used random-effects for meta-analysis and GRADE to assess the certainty of evidence. INCLUDED STUDIES: We meta-analysed 101 studies (50,325 participants) and narratively described 13 additional studies. RESULTS: Daily oral supplementation with iron alone versus no intervention/placebo Iron supplementation versus no intervention/placebo makes little to no difference to height/length-for-age z-score ((H(L)AZ), MD -0.01, 95% CI -0.04 to 0.02; 17 studies, 5534 participants; high-certainty evidence); weight-for-height/length z-score ((W(H(L)Z), MD 0.06, 95% CI -0.03 to 0.14; 10 studies, 2683 participants; high-certainty evidence); cough (RR 0.98, 95% CI 0.86 to 1.11; 4 studies, 2259 participants; high-certainty evidence), fever (RR 0.97, 95% CI 0.92 to 1.02; 5 studies, 763 participants; high-certainty evidence), and respiratory illness (RR 1.01, 95% CI 0.87 to 1.18; 3 studies, 549 participants; high-certainty evidence), but probably decreases IDA (RR 0.24, 95% CI 0.20 to 0.30; 13 studies, 3193 participants; moderate-certainty evidence). Iron supplementation may result in little to no difference in vomiting (RR 1.09, 95% CI 0.83 to 1.43; 5 studies, 2208 participants; low-certainty evidence) and diarrhoea (RR 1.32, 95% CI 0.90 to 1.92; 5 studies, 2018 participants; low-certainty evidence), but evidence is very uncertain for constipation (RR 0.92, 95% CI 0.23 to 3.66; 6 studies, 1002 participants; very low-certainty evidence). Evidence is very uncertain, but supplementation may decrease anaemia (RR 0.49, 95% CI 0.38 to 0.63; 19 studies, 5093 participants; very low-certainty evidence) and ID (RR 0.29, 95% CI 0.15 to 0.57; 13 studies, 3977 participants; very low-certainty evidence), but may increase stool discolouration (RR 6.13, 95% CI 3.30 to 11.38; 3 studies, 315 participants; very low-certainty evidence). Daily supplementations of IFA versus folic acid (FA) alone No data were found. Daily oral supplementation of IFA versus no intervention/placebo IFA versus no intervention/placebo probably decreases ID (RR 0.17, 95% CI 0.08 to 0.39; 1 study, 225 participants; moderate-certainty evidence) and IDA (RR 0.15, 95% CI 0.07 to 0.37; 1 study, 225 participants; moderate-certainty evidence), but evidence is very uncertain about the effects on anaemia (RR 0.53, 95% CI 0.24 to 1.16; 5 studies, 1757 participants; very low-certainty evidence). IFA makes little to no difference to morbidity (diarrhoea: RR 1.06, 95% CI 0.98 to 1.15; 2 studies, 12,981 participants; high-certainty evidence; or respiratory illness: RR 1.04, 95% CI 0.90 to 1.21; 1 study, 12,679 participants; high-certainty evidence). Daily oral supplementation of iron with vitamins/minerals versus the supplementation of the same vitamins/minerals without iron Supplementation of iron with vitamins/minerals makes little to no difference to H(L)AZ (MD -0.08, 95% CI -0.17 to -0.00; 7 studies, 1638 participants; high-certainty evidence), WH(L)Z (MD 0.00, 95% CI -0.10 to 0.10; 6 studies, 1376 participants; high-certainty evidence), and diarrhoea (RR 0.93, 95% CI 0.85 to 1.02; 4 studies, 1038 participants; high-certainty evidence). Iron supplementation probably decreases IDA (RR 0.16, 95% CI 0.07 to 0.38; 4 studies, 559 participants; moderate-certainty evidence); probably makes little to no difference to cough (RR 0.92, 95% CI 0.71 to 1.20; 2 studies, 430 participants; moderate-certainty evidence) and respiratory illness (RR 1.04, 95% CI 0.84 to 1.27; 2 studies, 430 participants; moderate-certainty evidence), and probably increases vomiting (RR 1.50, 95% CI 1.11 to 2.02; 1 study, 243 participants; moderate-certainty evidence). Evidence is very uncertain, but iron supplementation may decrease anaemia (RR 0.63, 95% CI 0.46 to 0.87; 9 studies, 1772 participants; very low-certainty evidence); however, the effects on ID (RR 0.31, 95% CI 0.05 to 1.79; 5 studies, 923 participants; very low-certainty evidence) and fever (RR 1.20, 95% CI 0.71 to 2.03; 2 studies, 430 participants; very low-certainty evidence) are very uncertain. Daily oral supplementation of iron with vitamins/minerals versus no intervention/placebo Supplementation of iron with vitamins/minerals versus no intervention/placebo increases H(L)AZ (MD 0.08, 95% CI 0.04 to 0.11; 10 studies, 1525 participants; high-certainty evidence) and probably decreases ID (RR 0.23, 95% CI 0.10 to 0.55; 9 studies, 1254 participants; moderate-certainty evidence). Iron supplementation may increase vomiting (RR 1.96, 95% CI 1.29 to 2.96; 1 study, 162 participants; low-certainty evidence; 0-5 month-old infants) but may decrease IDA (RR 0.30, 95% CI 0.11 to 0.83; 6 studies, 912 participants; low-certainty evidence), and may reduce anaemia, but the evidence is very uncertain (RR 0.65, 95% CI 0.50 to 0.83; 13 studies, 2254 participants; very low-certainty evidence). Evidence is very uncertain about the effects on cough (RR 0.92, 95% CI 0.68 to 1.25; 2 studies, 387 participants; very low-certainty evidence), fever (RR 0.86, 95% CI 0.48 to 1.53; 2 studies, 290 participants; very low-certainty evidence), respiratory illness (RR 0.71, 95% CI 0.38 to 1.34; 4 studies, 14,061 participants; very low-certainty evidence), and diarrhoeal morbidity (RR 0.72, 95% CI 0.23 to 2.21; 3 studies, 13,861 participants; very low-certainty evidence). AUTHORS' CONCLUSIONS: Daily oral supplementation of iron alone, iron with FA, or iron with vitamins/minerals may result in a significant reduction of iron-deficiency anaemia across our target population with little to no difference in morbidity, and a probable increase in stool discolouration. FUNDING: Cornell Joan Klein Jacobs Center for Precision Nutrition and Health, Cornell University, (USA); World Health Organization (Switzerland) REGISTRATION: Protocol (2018) DOI: https://doi.org/10.1002/14651858.CD013227.
No takes yet. Share an insight, caveat, or question.
Rajagopalan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: